Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-08

Clinical Trial Update: Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating glucosamine and chondroitin for joint symptoms in women taking aromatase inhibitors for breast cancer; trial completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chondroitin (chondroitin)
  • Glucosamine (glucosamine)

Snippet

Sponsor: Dawn L. Hershman | Conditions: Breast Cancer, Joint Pain | Phase 2 | Status: COMPLETED | Results posted: 2022-11-08